Literature DB >> 25734239

Most participate in faecal immunochemical test-based colorectal cancer screening out of curiosity about their chances of developing cancer.

Maaike J Denters1, Patrick M Bossuyt, Marije Deutekom, Paul Fockens, Evelien Dekker.   

Abstract

Several clinical trials have shown that colorectal cancer (CRC) screening can reduce cancer deaths. Its effectiveness is affected by the participation level. To develop targeted invitations, we need to understand why individual persons decide to participate. To evaluate reasons for participation among persons invited for faecal immunochemical test-based CRC screening, a total of 10,265 asymptomatic persons aged 50-75 years were invited to a Dutch CRC screening pilot (2008-2009). Reasons for participation were elicited by a questionnaire. A total of 3554 (66%) participants returned the questionnaire. Obtaining more certainty about the chances of developing cancer (ticked by 88%) and the occurrence of cancer in the family or the circle of acquaintances (18%) were the most frequently selected reasons for participation. We also explored reasons for nonparticipation among nonparticipants. In this subgroup, comorbidity and the absence of symptoms were the most frequently reported reasons for declining to participate, but the response rate was low. The vast majority of the participants decided to take up the screening because they wanted to know more about their chances of developing cancer.

Entities:  

Mesh:

Year:  2015        PMID: 25734239     DOI: 10.1097/CEJ.0000000000000139

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  3 in total

1.  Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.

Authors:  Manon van der Vlugt; Esmée J Grobbee; Patrick Mm Bossuyt; Evelien Bongers; Wolfert Spijker; Ernst J Kuipers; Iris Lansdorp-Vogelaar; Marie-Louise Essink-Bot; Manon C W Spaander; Evelien Dekker
Journal:  Br J Cancer       Date:  2016-12-06       Impact factor: 7.640

2.  What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?

Authors:  Louisa Flander; Evelien Dekker; Berit Andersen; Mette Bach Larsen; Robert J Steele; Nea Malila; Tytti Sarkeala; Manon van der Vlugt; Clasine de Klerk; Bart Knottnerus; Lucinda Bertels; Anke Woudstra; Manon C W Spaander; Mirjam Fransen; Sirpa Heinavaara; Mary Dillon; Driss Ait Ouakrim; Mark Jenkins
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

3.  Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study.

Authors:  Anna Lisa Schult; Edoardo Botteri; Geir Hoff; Kristin R Randel; Eirin Dalén; Sigrun Losada Eskeland; Øyvind Holme; Thomas de Lange
Journal:  BMJ Open       Date:  2021-07-01       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.